Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 known ✓ | Q92731 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | NPC1 | O15118 | 2/20 | 0.56 |
| ▸ | RAB9A | P51151 | 2/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29981558 | 1.00 | ALDH1A1 (0.58) | ALDH1A1TDP1NPC1RAB9ARECQL | |
| Water SCHEMBL14844541 | 0.98 | ALDH1A1 (0.56) | ALDH1A1TDP1NPC1RAB9ARECQL | |
| SCHEMBL36924 | 0.86 | ALDH1A1 (0.60) | ALDH1A1TDP1NPC1RAB9ARECQL | |
| SCHEMBL6377819 | 0.83 | ALDH1A1 (0.56) | ALDH1A1TDP1NPC1RAB9ARECQL | |
| SCHEMBL6009724 | 0.83 | ALDH1A1 (0.56) | ALDH1A1TDP1NPC1RAB9ARECQL | |
| SCHEMBL30679480 | 0.83 | ALDH1A1 (0.56) | ALDH1A1TDP1NPC1RAB9ARECQL | |
| SCHEMBL8085362 | 0.83 | ALDH1A1 (0.56) | ALDH1A1TDP1NPC1RAB9ARECQL | |
| SCHEMBL36926 | 0.83 | ALDH1A1 (0.56) | ALDH1A1TDP1NPC1RAB9ARECQL | |
| SCHEMBL2474283 | 0.83 | ALDH1A1 (0.56) | ALDH1A1TDP1NPC1RAB9ARECQL | |
| SCHEMBL36925 | 0.83 | ALDH1A1 (0.56) | ALDH1A1TDP1NPC1RAB9ARECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119685445-A | Analysis method and device for detecting activity of acid phosphatase in soil | 苏州梦犀生物医药科技有限公司 | 2025-03-25 | — | — | CN | claimed |
| CN-118994612-A | Sheet zirconium-based metal organic framework material Zr-MOF, and preparation method and application thereof | 中山大学 | 2024-11-22 | — | — | CN | claimed |
| CN-114199660-B | Quality control product for detecting preassembled reagent of microfluidic chip and preparation method thereof | 阿里生物技术泰州有限公司 | 2024-03-19 | — | — | CN | claimed |
| CN-114199660-A | Quality control product for detecting microfluidic chip pre-packaged reagent and preparation method thereof | 阿里生物技术泰州有限公司 | 2022-03-18 | — | — | CN | claimed |
| US-20260000753-A1 | CONSTRUCTS FOR ENHANCING IMMUNE RESPONSES | WISTAR INST (US) | 2026-01-01 | — | — | US | disclosed |
| US-12390525-B2 | Constructs for enhancing immune responses | THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY (US) | 2025-08-19 | — | — | US | disclosed |
| CN-119916022-A | SND1 protein kit and application thereof | 天津大学四川创新研究院 | 2025-05-02 | — | — | CN | disclosed |
| CN-119685445-A | Analysis method and device for detecting activity of acid phosphatase in soil | 苏州梦犀生物医药科技有限公司 | 2025-03-25 | — | — | CN | disclosed |
| CN-119685445-A | Analysis method and device for detecting activity of acid phosphatase in soil | 苏州梦犀生物医药科技有限公司 | 2025-03-25 | — | — | CN | disclosed |
| CN-119504307-A | Saline-alkali soil conditioner and application thereof | 中国农业大学 | 2025-02-25 | — | — | CN | disclosed |
| CN-118718951-A | Paranitrophosphate disodium production system | 深圳瑞亚力集团有限公司 | 2024-10-01 | — | — | CN | disclosed |
| CN-118604348-A | Method for quantifying antigen-specific antibody reaction in bovine peripheral blood and application thereof | 扬州大学 | 2024-09-06 | — | — | CN | disclosed |
| US-5589344-A | DIAGNOSTICS | JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) | 1996-12-31 | — | — | US | disclosed |
| US-5565326-A | ONE STEP CHEMICAL ANALYSIS BY RECEPTOR BINDING ASSAY | JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) | 1996-10-15 | — | — | US | disclosed |
| WO-1996011709-A1 | SYNTHESIS OF TYPHOID FEVER VACCINE FROM A PLANT OR FRUIT POLYSACCHARIDE | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1996-04-25 | — | — | WO | disclosed |
| EP-0687910-A1 | Test kit and method for competitive specific binding assay | Johnson & Johnson Clinical Diagnostics, Inc. (US) | 1995-12-20 | — | — | EP | disclosed |
| EP-0685740-A2 | Separation-free specific binding assays using anti-inhibitor antibodies | Johnson & Johnson Clinical Diagnostics, Inc. (US) | 1995-12-06 | — | — | EP | disclosed |
| EP-0680338-A1 | GANGLIOSIDE-KLH CONJUGATE VACCINES WITH QS-21 | Sloan-Kettering Institute For Cancer Research (US) | 1995-11-08 | — | — | EP | disclosed |
| WO-1994016731-A1 | GANGLIOSIDE-KLH CONJUGATE VACCINES WITH QS-21 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1994-08-04 | — | — | WO | disclosed |
| CN-1089257-A | N-phenylthiourea derivatives and pharmaceutical use thereof | SANDOZ LTD (CH) | 1994-07-13 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260000753-A1 | CONSTRUCTS FOR ENHANCING IMMUNE RESPONSES | CD74, CD47, HAVCR2 | ESR2 2573/4885ALDH1A1 4492/4885TDP1 3597/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.